These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26194889)

  • 21. Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis.
    Wu PK; Chen CF; Chung LH; Liu CL; Chen WM
    Thromb Res; 2014 May; 133(5):719-24. PubMed ID: 24593913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
    Fisher WD; Eriksson BI; Bauer KA; Borris L; Dahl OE; Gent M; Haas S; Homering M; Huisman MV; Kakkar AK; Kälebo P; Kwong LM; Misselwitz F; Turpie AG
    Thromb Haemost; 2007 Jun; 97(6):931-7. PubMed ID: 17549294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rivaroxaban versus standard of care in venous thromboembolism prevention following hip or knee arthroplasty in daily clinical practice (Spanish data from the international study XAMOS)].
    Granero J; Díaz de Rada P; Lozano LM; Martínez J; Herrera A;
    Rev Esp Cir Ortop Traumatol; 2016; 60(1):44-52. PubMed ID: 26194908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opportunities for improvement: anticoagulation in patients undergoing total knee or hip replacement.
    Thorsberger M; Jensen T; Olesen J; Weeke P; Wahlsten L; Jensen P; Gislason G; Torp-Pedersen C; Koeber L; Fosbøl E
    J Orthop Sci; 2015 Nov; 20(6):1036-45. PubMed ID: 26293801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Ma G; Zhang R; Wu X; Wang D; Ying K
    Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis.
    Kwong LM
    Orthopedics; 2012 Jun; 35(6):e932-8;discussion e939. PubMed ID: 22691670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation.
    Green L; Lawrie AS; Patel S; Hossain F; Chitolie A; Mackie IJ; Haddad FS; Machin SJ
    Br J Haematol; 2010 Dec; 151(5):469-76. PubMed ID: 20950405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apixaban. After hip or knee replacement: LMWH remains the standard treatment.
    Prescrire Int; 2012 Sep; 21(130):201-2, 204. PubMed ID: 23016247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial.
    Verhamme P; Gunn S; Sonesson E; Peerlinck K; Vanassche T; Vandenbriele C; Ageno W; Glazer S; Prins M; Buller H; Tangelder M
    Thromb Haemost; 2013 Jun; 109(6):1091-8. PubMed ID: 23615791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between deep vein thrombosis and pulmonary embolism following THA and TKA.
    Bosque J; Coleman SI; Di Cesare P
    Orthopedics; 2012 Mar; 35(3):228-33; quiz 234-5. PubMed ID: 22385601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
    Raskob G; Cohen AT; Eriksson BI; Puskas D; Shi M; Bocanegra T; Weitz JI
    Thromb Haemost; 2010 Sep; 104(3):642-9. PubMed ID: 20589317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.
    Eriksson BI; Kakkar AK; Turpie AG; Gent M; Bandel TJ; Homering M; Misselwitz F; Lassen MR
    J Bone Joint Surg Br; 2009 May; 91(5):636-44. PubMed ID: 19407299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.
    Turpie AG; Lassen MR; Eriksson BI; Gent M; Berkowitz SD; Misselwitz F; Bandel TJ; Homering M; Westermeier T; Kakkar AK
    Thromb Haemost; 2011 Mar; 105(3):444-53. PubMed ID: 21136019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rivaroxaban versus nadroparin for preventing deep venous thrombosis after total hip arthroplasty following femoral neck fractures: A retrospective comparative study.
    Zhang C; Xu B; Liang G; Zeng X; Yang C; Zhang F; Wan Z; Yu W; Chen D; Ge Z; Zhang X
    J Int Med Res; 2018 May; 46(5):1936-1946. PubMed ID: 29560772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban.
    Tardy-Poncet B; Piot M; Montmartin A; Burdier A; Chalayer E; Tardy B
    Thromb Haemost; 2015 Aug; 114(3):652-4. PubMed ID: 26062524
    [No Abstract]   [Full Text] [Related]  

  • 36. Dabigatran vs. low molecular weight heparin in preventing venous thromboembolism after elective hip and knee arthroplasty: evaluation of selected clinical parameters.
    Mrozik D; Jackiewicz A; Krzemiński M
    Pol Orthop Traumatol; 2012 Oct; 77():111-4. PubMed ID: 23306297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of rivaroxaban for chemical thromboprophylaxis following total knee replacement.
    Rath NK; Goodson MW; White SP; Forster MC
    Knee; 2013 Dec; 20(6):397-400. PubMed ID: 23566737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
    Raskob GE; Gallus AS; Pineo GF; Chen D; Ramirez LM; Wright RT; Lassen MR
    J Bone Joint Surg Br; 2012 Feb; 94(2):257-64. PubMed ID: 22323697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Case-control study on three antithrombotic agents for the prevention of venous thromboembolism after unilateral total knee arthroplasty].
    Miao SG; Zhang XG; Lu JH; Yang Y; Lu N
    Zhongguo Gu Shang; 2015 Oct; 28(10):893-6. PubMed ID: 26727779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study.
    Jensen CD; Steval A; Partington PF; Reed MR; Muller SD
    J Bone Joint Surg Br; 2011 Jan; 93(1):91-5. PubMed ID: 21196550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.